Filing Flows

Filing Flows › Companies › Hinge Health › Cash flow

Hinge Health cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$101M in Q2 2026 · $290M over twelve months

Operating cash flow$101M
Capital spending−$123K
Free cash flow+$101M
Cash / net income2.3×
Cash conversion cycle-105 days

Analysis

In Q2 2026, Hinge Health generated $101M of operating cash flow and spent $123K on capital projects, leaving free cash flow of $101M. That is $81.3M more than in Q2 2025 ($20.0M).

Over the twelve months to Jun 30, 2026, operating cash flow was $291M; the largest uses were buybacks ($197M), taxes on employees’ shares ($42.8M), other investing ($19.1M); besides operations, cash came from shares issued ($17.2M); the cash balance rose by $48.7M.

Operating cash flow was $101M against net income of $43.7M — 2.3× profit, cash ran ahead of reported earnings. The largest differences: deferred revenue +$75.7M, stock-based pay +$19.1M, receivables −$12.1M.

Its cash conversion cycle was -105 days (receivables 51 + inventory 49 − payables 205): suppliers fund its working capital.

Free cash flow

Hinge Health: free cash flow by quarterHinge Health: free cash flow by quarter$28.1MQ3 2024$38.2MQ4 2024$4.9MQ1 2025$20.0MQ2 2025$82.3MQ3 2025$63.5MQ4 2025$43.0MQ1 2026$101MQ2 2026
Operating cash flow less capital spending.
Hinge Health: operating cash flow against capital spendingHinge Health: operating cash flow against capital spendingOperating cash flowCapital spending$28.4M$315KQ3 2024$38.3M$157KQ4 2024$4.9M$51KQ1 2025$20.2M$197KQ2 2025$82.4M$52KQ3 2025$63.9M$408KQ4 2025$43.1M$83KQ1 2026$101M$123KQ2 2026
Latest (Q2 2026): Operating cash flow $101M, Capital spending $123K.

Capital allocation, year by year

Hinge Health: where the cash came from (up) and went (down), by fiscal yearHinge Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedCapital spendingAcquisitionsBuybacksFY2023: Operating cash flow −$63.9MFY2023: Shares issued $492KFY2023: Capital spending −$2.0M$492KFY2023FY2024: Operating cash flow $49.0MFY2024: Shares issued $610KFY2024: Capital spending −$1.0M$49.6MFY2024FY2025: Operating cash flow $171MFY2025: Shares issued $9.5MFY2025: Capital spending −$708KFY2025: Acquisitions −$4.0MFY2025: Buybacks −$65.0M$181MFY2025
Over these 3 years operating cash flow totalled $157M; the largest uses were buybacks ($65.0M) and operating cash flow ($63.9M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$389M
Debtnone
Net cash$389M

Hinge Health funds itself: free cash flow was $290M over the last twelve months, with $389M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Hinge Health: sources (+) and uses (−) of cash, Q2 2026Hinge Health: sources (+) and uses (−) of cash, Q2 2026Operating cash flow$101MCash drawn (+) / kept (−)−$99.6MOther investing$28.7MBuybacks−$26.5MTaxes on employees’ shares−$11.5MOther financing$7.3MShares issued$270KCapital spending−$123K
Hinge Health: sources (+) and uses (−) of cash, TTM to Q2 2026Hinge Health: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow$291MBuybacks−$197MCash drawn (+) / kept (−)−$48.7MTaxes on employees’ shares−$42.8MOther investing−$19.1MShares issued$17.2MCapital spending−$666KOther financing−$288K

From profit to cash

Hinge Health: net income to operating cash flow, Q2 2026Hinge Health: net income to operating cash flow, Q2 2026Net income$43.7MDepreciation & amortization$1.1MStock-based pay$19.1MDeferred taxes$13KOther non-cash−$1KReceivables−$12.1MInventory−$2.6MPayables−$8.7MDeferred revenue$75.7MPrepaid and other assets$331KOperating cash flow$101M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20265149205-105
Q1 20264548203-111
Q4 20254151190-99
Q3 20255646145-44

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026$101M−$123K—−$26.5M$270K−$99.6M$101M
Q1 2026$43.1M−$83K—−$105M$410K$21.7M$43.0M
Q4 2025$63.9M−$408K——$629K$53.3M$63.5M
Q3 2025$82.4M−$52K——$531K−$24.2M$82.3M
Q2 2025$20.2M−$197K——$159K$51.3M$20.0M
Q1 2025$4.9M−$51K−$4.0M—$97K$12.3M$4.9M
Q4 2024$38.3M−$157K——$208K−$32.9M$38.2M
Q3 2024$28.4M−$315K——$125K−$30.9M$28.1M

Hinge Health: income statement and cash flow

Hinge Health, Q3 2026: revenue $235M (+52% year over year), operating margin 21.4%. The chart follows the revenue to costs, profit and cash.

Hinge Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.